Top Abstract Purchase Related
Home
>
Node
>
Subnode

Management of disseminated disease in the patient with bladder cancer

Perry, J.J.; Muss, H.B.

Urologic Clinics of North America 21(4): 661-672

1994

ISSN/ISBN: 0094-0143
PMID: 7974898
Document Number: 425824
Advanced transitional cell carcinoma of the bladder is a chemotherapy-sensitive neoplasm. Several single agents demonstrate substantial activity, and combination chemotherapy produces responses in the majority of patients treated. The benefits and toxicities associated with the most widely used combination regimens are discussed. Other topics reviewed include the use of colony-stimulating factor support for chemotherapy, adjunctive surgical therapy, and newer cytotoxic regimens.

Document emailed within 1 workday
Secure & encrypted payments

Freeman, J.A.; Esrig, D.; Stein, J.P.; Skinner, D.G. 1994: Management of the patient with bladder cancer. Urethral recurrence Urologic Clinics of North America 21(4): 645-651
Aihara, R.; Sato, K.; Sasaki, K.; Hosaka, Y.; Narita, T. 1985: Pre and postoperative nursing of patients with bladder cancer. Nursing of a patient in the terminal stage of bladder cancer with poor prognosis Nursing Technique 31(11): 1492-1497
1998: Stable coronary artery disease. Ongoing management, patient management, patient education, and medical interventions. Institute for Clinical Systems Integration Postgraduate Medicine 104(2): 157-64 169
Koch, H.J.; Szecsey, A.; Raschka, C. 2001: Severe bradyarrhythmia in a patient with Alzheimer's disease and a patient with cerebral ischaemia, both induced by acute distension of the bladder International Journal of Clinical Practice 55(5): 323-325
Wolkenstein, P.; Consoli, S.; Roujeau, J.C.; Grob, J.J. 2002: The physician-patient relation. Reporting a severe disease. Education of a patient suffering from a chronic disease. Personalizing medical management Annales de Dermatologie et de Venereologie 129(10 Suppl): S7-10
García-de la Torre, I.; Lascuráin-Morhan, E.; Monsebáiz, F. 1985: Disseminated nocardiosis in a patient with mixed connective tissue disease Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 37(4): 369-371
Padhy, B.P. 2014: Disseminated intra-abdominal hydatid disease: surgical management Journal of the Indian Medical Association 112(2): 119-120
Hegarty, P.K.; Kamat, A.M. 2008: Management of bladder cancer Minerva Urologica e Nefrologica 60(4): 255-264
Bonnal, J.-L.; Irani, J.; Maidenberg, M.; Théodore, C.; Mauroy, B. 2003: Management of bladder cancer associated with prostate cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(6): 1286-1289
Kondás, J.; Szentgyörgyi, E.; Diószeghy, G.; Váczi, L.; Kiss, A. 1994: Cystectomy in the management of bladder cancer Orvosi Hetilap 135(3): 119-124
Oshima, Y. 1979: Dermal lesions in hematological diseases and their care - nursing of a patient with disseminated eosinophilic collagen disease Nursing Technique 25(12): 70-76
Azzouz, H.; Cauberg, E.C.C.; De Reijke, T.M. 2011: Controversies in the management of T1 urothelial bladder cancer Minerva Urologica e Nefrologica 63(4): 309-315
Grossman, H.Barton. 2007: Improving the management of bladder cancer with fluorescence cystoscopy Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 26(2): 143-147
Fradet, Y. 1991: Molecular and immunologic approaches in the management of bladder cancer Urologic Clinics of North America 18(3): 515-524
Zungri, E.; Martinez, L.; Da Silva, E.A.; Pesqueira, D.; de la Fuente Buceta, A.; Pereiro, B. 1999: T1 GIII bladder cancer. Management with transurethral resection only European Urology 36(5): 380-4; Discussion 384-5
Torelli, T.; Leidi, G.L.; Corrada, P.; Bacchioni, A.M.; Ordesi, G.; Zanitzer, L.; Campo, B. 1988: The role of partial cystectomy in the management of transitional bladder cancer Tumori 74(2): 233-236
Henry, N.L.; MacVicar, G.; Hussain, M. 2005: Management of patients with muscle-invasive and metastatic bladder cancer Oncology 19(10): 1333-1342; Discussion 1342 1347 1350 Passim
Del Zingaro, M.; Bruno, R.; Nunzi, E.; Porena, M.; Mearini, L. 2016: First and second transurethral resections in intermediate-high risk bladder cancer: impact of the surgeon's volume on the recurrence and progression of primary bladder cancer Minerva Urologica e Nefrologica 68(2): 194-203
Rissanen, A.-M.; Pekonen, M.; Terho, R.; Krees, R.; Katila, M.-L. 2002: Enlarged pelvic lymph nodes after immunotherapy in a patient with bladder cancer Duodecim; Laaketieteellinen Aikakauskirja 118(10): 1029-1032
Bourlon, M.ía.T.; Velázquez, H.E.; Luna-Santiago, R.; Vázquez-Manjarrez, S.; Bourlon, C. 2018: Is this Patient with Metastatic Bladder Cancer a Candidate for Second-Line Immunotherapy Treatment? Oncology 32(2): 64-68